The global Transplant Diagnostic Market reached a valuation of USD 4.43 Billion in 2022 and is projected to attain USD 8.86 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8% throughout the forecast period. The escalation in the incidence of chronic ailments like cancer, kidney disease, and heart failure has resulted in a surge in organ transplantation procedures, thereby propelling the market's revenue growth. The necessity for pre-transplant compatibility assessments and post-transplant organ rejection monitoring has generated substantial demand for transplant diagnostic tests.
Furthermore, the adoption of advanced transplant diagnostic technologies, including next-generation sequencing, molecular diagnostic assays, and non-invasive diagnostic testing, is augmenting revenue growth in the market. These cutting-edge technologies provide precise and rapid results, crucial for making timely and effective transplant-related decisions. Additionally, the increasing utilization of personalized medicine and the demand for tailor-made treatment regimens for patients are driving the need for transplant diagnostic testing.
Get Free Sample PDF (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/4039
Another significant driver of market revenue growth is the development of targeted therapies and immunosuppressive medications. To ensure patient safety and minimize side effects, the monitoring of these therapies and medications must be highly precise. Furthermore, the pharmaceutical industry is experiencing an upswing in demand for transplant diagnostic tests, particularly for applications in clinical trials.
Key players in the Transplant Diagnostic Market:
- Thermo Fisher Scientific, Inc.
- Qiagen N.V.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd.
- Illumina, Inc.
- Becton, Dickinson and Company
- Abbott Laboratories
- DiaSorin S.p.A.
- CareDx, Inc.
- Hologic, Inc.
Some key highlights from the report:
- The molecular assay technologies segment dominated other technology type segments in the global market in terms of revenue in 2020. Segment revenue is expected to increase significantly over the forecast period due to rising adoption of transplant diagnostic techniques, technological advancements in these methods, and increasing adoption of PCR-based technologies for improved accuracy, lesser turnaround time, real-time sample analysis, and lower risks.
- The independent reference laboratories segment leads among the end-use segments, and is expected to continue to account for largest revenue share over the forecast period. Increasing number of organ transplant procedures, surge in pharmaceutical and biotechnological research & development activities, and rapid automation of diagnostic laboratories are some key factors driving revenue growth of this segment.
- The transplant diagnostics market in North America led among other regional markets in the global market in terms of revenue in 2020. Surging number of organ transplant procedures, fast-paced adoption of advanced diagnostic techniques, and increasing government initiatives to raise awareness about organ donation are factors supporting growth of the North America market.
Transplant Diagnostic Market Report Scope
By Product Type Outlook
- Molecular Assays
- Non-Molecular Assays
By Application Outlook
- Pre-Transplantation
- Post-Transplantation
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/4039
Explore Trending Reports:
Head and Neck Squamous Cell Carcinoma Treatment Market - https://www.reportsanddata.com/report-detail/head-and-neck-squamous-cell-carcinoma-treatment-market
Pheochromocytoma Market - https://www.reportsanddata.com/report-detail/pheochromocytoma-market
Polyangiitis Market - https://www.reportsanddata.com/report-detail/polyangiitis-market
View Latest Articles by Reports and Data:
Microcatheters Market - https://www.biospace.com/article/microcatheters-market-demand-2022-2028-rising-prevalence-of-chronic-illnesses-such-as-neurovascular-and-cardiovascular-problems/
Alzheimer's Pipeline Drug Market - https://www.biospace.com/article/alzheimer-s-pipeline-drug-market-growth-by-2027-geriatric-people-will-attract-the-maximum-demand-for-these-drugs/
Insulin Delivery Devices Market - https://www.biospace.com/article/insulin-delivery-devices-market-growth-2022-2028-increasing-awareness-of-insulin-delivery-devices-and-ongoing-research-and-development-activities-in-the-field/
HLA Typing for Transplant Market - https://www.biospace.com/article/hla-typing-for-transplant-market-growth-2022-2028-growing-incidence-of-chronic-diseases-and-rising-demand-for-organ-transplantation/
Defibrillator Market - https://www.biospace.com/article/defibrillator-market-size-2022-2028-increase-in-implementation-of-technologically-advanced-defibrillators-upward-demand-for-superiority-medical-care-and-cardiovascular/
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
